MRP1 knockdown down-regulates the deposition of collagen and leads to a reduced hypertrophic scar fibrosis

[1]  Huijun Sun,et al.  Decreased liver distribution of entecavir is related to down-regulation of Oat2/Oct1 and up-regulation of Mrp1/2/3/5 in rat liver fibrosis. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  Huijun Sun,et al.  Protective Effects of Calycosin Against CCl4-Induced Liver Injury with Activation of FXR and STAT3 in Mice , 2015, Pharmaceutical Research.

[3]  Huijun Sun,et al.  Alisol B 23-acetate promotes liver regeneration in mice after partial hepatectomy via activating farnesoid X receptor. , 2014, Biochemical pharmacology.

[4]  S. Cole.  Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future. , 2014, Annual review of pharmacology and toxicology.

[5]  S. Canevari,et al.  Clinicopathological Impact of ABCC1/MRP1 and ABCC4/MRP4 in Epithelial Ovarian Carcinoma , 2013, BioMed research international.

[6]  P. Souček,et al.  The expression profile of ATP-binding cassette transporter genes in breast carcinoma. , 2013, Pharmacogenomics.

[7]  Wei Huang,et al.  Elevated expression of pleiotrophin in human hypertrophic scars , 2012, Journal of Molecular Histology.

[8]  X. Bai,et al.  Reduced expression of microtubule-associated protein 1 light chain 3 in hypertrophic scars , 2012, Archives of Dermatological Research.

[9]  M. Longaker,et al.  Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling , 2011, Nature Medicine.

[10]  X. Bai,et al.  Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars. , 2011, Burns : journal of the International Society for Burn Injuries.

[11]  R. Piñeiro,et al.  The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation , 2011, Oncogene.

[12]  Jian Li,et al.  Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy. , 2010, Lung cancer.

[13]  A Bayat,et al.  The hidden cost of skin scars: quality of life after skin scarring. , 2008, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[14]  C. Feghali-Bostwick,et al.  Human Skin Culture as an Ex Vivo Model for Assessing the Fibrotic Effects of Insulin-Like Growth Factor Binding Proteins , 2008, The open rheumatology journal.

[15]  David S. Rosenberg,et al.  Temporal expression of the transforming growth factor-Beta pathway in the rabbit ear model of wound healing and scarring. , 2007, Journal of the American College of Surgeons.

[16]  S. Cole,et al.  Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. , 2006, Physiological reviews.

[17]  J. Bernaudin,et al.  Evaluation of MRP1-5 Gene Expression in Cystic Fibrosis Patients Homozygous for the ΔF508 Mutation , 2003, Pediatric Research.

[18]  H. Aburatani,et al.  ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. , 2002, Biochemical and biophysical research communications.

[19]  S. Frankenberg,et al.  Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. , 2001, The Journal of investigative dermatology.

[20]  A Rzhetsky,et al.  The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Journal of lipid research.

[21]  R. Parwaresch,et al.  T lymphocytes and altered keratinocytes express interferon-γ and interleukin 6 in lichen planus , 1999, Archives of Dermatological Research.

[22]  Jos H. Beijnen,et al.  Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein , 1997, Nature Medicine.

[23]  D. Ladin,et al.  Acute and Chronic Animal Models for Excessive Dermal Scarring: Quantitative Studies , 1997, Plastic and reconstructive surgery.

[24]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[25]  P. Sehgal.  Interleukin-6: molecular pathophysiology. , 1990, The Journal of investigative dermatology.

[26]  J. Russell,et al.  CELL SIZE AND GROWTH CHARACTERISTICS OF CULTURED FIBROBLASTS ISOLATED FROM NORMAL AND KELOID TISSUE , 1976, Plastic and reconstructive surgery.

[27]  D. Hu,et al.  Wnt/β-catenin pathway forms a negative feedback loop during TGF-β1 induced human normal skin fibroblast-to-myofibroblast transition. , 2012, Journal of dermatological science.

[28]  R. Parwaresch,et al.  T lymphocytes and altered keratinocytes express interferon-gamma and interleukin 6 in lichen planus. , 1999, Archives of dermatological research.

[29]  J. Riordan.  Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA , 1989 .